Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Alexandra Barsan (Bujor) has a total of 50 co-authors. Here are the top co-authors by number of shared publications:

  • Lacramioara Ochiuz

    Department of Pharmaceutical Technology, Faculty of Pharmacy, “Grigore T. Popa” University of Medicine and Pharmacy, 16 Universității Street, 700115 Iași, Romania

    10 shared publications
  • Mousa Sha’at

    Department of Pharmaceutical Technology, Faculty of Pharmacy, “Grigore T. Popa” University of Medicine and Pharmacy, 16 Universității Street, 700115 Iași, Romania

    8 shared publications
  • Monica Stamate Cretan

    Department of Pharmaceutical Technology, Faculty of Pharmacy, “Grigore T. Popa” University of Medicine and Pharmacy, 16 Universității Street, 700115 Iași, Romania

    7 shared publications
  • Adrian Spac

    Faculty of Pharmacy, “Grigore T. Popa” University of Medicine and Pharmacy Iasi, 16th University Str., 700115 Iasi, Romania

    5 shared publications
  • Anca Miron

    Faculty of Pharmacy, Grigore T. Popa University of Medicine and Pharmacy, 700115 Iași, Romania

    5 shared publications
  • Maricel Agop

    Department of Environmental Engineering, Mechanical Engineering and Agritourism, Faculty of Engineering, “Vasile Alecsandri” University of Bacău, 600115 Bacău, Romania

    5 shared publications

Latest Publications

  • Open Access

    Experimental and Statistical Studies in the Development of Ketoprofen–Hydroxypropyl-β-Cyclodextrin Inclusion Complexes for Application in Compressed Tablets

    by Monica Stamate Cretan, Lacramioara Ochiuz, Camelia-Elena Iurciuc-Tincu, Carmen Anatolia Gafițanu, Alexandra Barsan (Bujor), Mousa Sha’At, Ciprian Stamate

    Ketoprofen is a Biopharmaceutics Classification System (BCS) class II non-steroidal anti-inflammatory drug whose therapeutic performance is limited by its poor aqueous solubility, though complexation with cyclodextrins is a well-established strategy to overcome this limitation. The aim of this work was to prepare and characterize inclusion complexes of ketoprofen with HPβCD. Complexes were obtained by the solution (magnetic-stirring) method at ketoprofen–HPβCD molar ratios of 1:1 and 2:1 and were characterized by Fourier-transform infrared spectroscopy (FT-IR), differential scanning calorimetry (DSC), scanning electron microscopy (SEM) coupled with EDX, and computer-assisted dimensional analysis and statistics (AutoCAD/MathCAD). The bulk and tapped densities were used to derive the Carr index and the Hausner ratio, respectively. FT-IR showed attenuation and shifting of the characteristic C=O, C=C, and –CH bands of ketoprofen and the presence of the 1655 cm−1 band in complexes demonstrates inclusion. DSC revealed a marked reduction of the ketoprofen melting endotherm, the degree of inclusion reaching 75% (1:1) and 62% (2:1). SEM and statistical analysis confirm, individualized particles, predominantly 20–100 µm in perimeter size. The dissolution test showed a faster release of the complexes than in the case of pure ketoprofen. Therefore, HPβCD forms stable inclusion complexes with ketoprofen having pharmacotechnical properties suitable for compressed tablets.

  • Open Access

    Multifractal Model for Oromucosal Polymeric Film Performance

    by Alexandra Barsan (Bujor), Vlad Ghizdovat, Monica Stamate Cretan, Mousa Sha’At, Carmen Anatolia Gafitanu, Ciprian Stamate, Anca Miron, Dragos-Ioan Rusu, Maricel Agop, Lacramioara Ochiuz

    Background: Oromucosal films are thin polymeric dosage forms designed to hydrate rapidly in the oral cavity and enable local or systemic drug delivery. Their performance depends on coupled processes including wetting, swelling, polymer relaxation, matrix softening, and structural failure. Because these phenomena depend strongly on the formulation composition and polymer-network organization, a mechanistic framework linking conventional characterization data to film performance is needed. This study aimed to develop a Madelung-type multifractal swelling–disintegration–release-readiness model for chitosan/hydroxypropyl methylcellulose (HPMC) films and to examine its relevance using a twelve-formulation experimental series. Methods: Twelve films based on chitosan (film-forming polysaccharide), HPMC K-4M (hydrophilic swelling polymer), glycerin (plasticizer), and starch (disintegrant) were prepared via solvent casting. The films were characterized for loss on drying, surface pH, mass and thickness uniformity, wetting time, swelling behavior, structural-disintegration onset, elongation response, rupture resistance, folding endurance, and surface roughness. The proposed model described water uptake, swelling-front motion, matrix integrity, local release-readiness activation, and hydration-induced loading as coupled fields across the film thickness. Results: Formulation markedly influenced hydration behavior, mechanical performance, structural stability, and surface morphology. Films F2 and F7 emerged as the most promising complementary unloaded matrix platforms for future active-compound incorporation and experimental release evaluation. F2 behaved as a high-swelling, mechanically stable starch-free matrix, whereas F7 combined faster wetting, starch-assisted structural destabilization, and favorable flexibility. Conclusions: This framework provides a quantitative link between empirical film characterization and formulation-level mechanistic interpretation. It translates conventional characterization parameters into descriptors related to the apparent water penetration, swelling capacity, matrix-failure tendency, mechanical suitability, and structural heterogeneity. The present results support candidate selection for future Active Pharmaceutical Ingredient-loaded studies but do not constitute validation of drug-release kinetics.


  • Open Access

    Conifer Bark Extracts as Modulators of Endothelial Function: Evidence from Abies alba and Cedrus brevifolia

    by Alexandra Barsan (Bujor), Valeriu B. Cismasiu, Sevinci Pop, Corine Girard, Perle Totoson, Simon Vlad Luca, Krystyna Skalicka-Woźniak, Mihaela Lipovanu, Cristina Lungu, Lacramioara Ochiuz, et al.

    Conifer bark extracts have attracted growing interest for their potential to protect and support endothelial function. The objective of this study was to evaluate the effects of Abies alba Mill. and Cedrus brevifolia (Hook. f.) Henry bark extracts on vascular endothelial function. The bark extracts were characterized by liquid chromatography coupled to high-resolution mass spectrometry. Bioactivity studies were first conducted in EA.hy926 endothelial cells to investigate the effects of bark extracts on cell viability and proliferation, nitric oxide production, oxidative stress, and angiogenesis. The vasorelaxant effects of bark extracts in rat aortic rings, as well as their impact on in vitro arginase activity, were further assessed. Abies alba bark extract was more effective in enhancing nitric oxide production (8.8-fold vs. 7.4-fold at 0.1 mg/mL), reducing oxidative stress (by 33% vs. 26% at 0.1 mg/mL), and inhibiting angiogenesis in EA.hy926 endothelial cells. It also exhibited stronger arginase inhibitory activity (IC50 = 68.30 µg/mL vs. 115.31 µg/mL). Both bark extracts showed marked vasorelaxant activity (EC50 < 15 µg/mL), mainly mediated by an endothelial nitric oxide synthase-related mechanism, with the Cedrus brevifolia bark extract being more active. Overall, our findings indicate that both bark extracts are promising candidates for supporting endothelial function.


  • Open Access

    Development of Modified Drug Delivery Systems with Metformin Loaded in Mesoporous Silica Matrices: Experimental and Theoretical Designs

    by Mousa Sha’at, Maria Ignat, Florica Doroftei, Vlad Ghizdovat, Maricel Agop, Alexandra Barsan (Bujor), Monica Stamate Cretan, Fawzia Sha’at, Ramona-Daniela Pavaloiu, Adrian Florin Spac, et al.

    Background/Objectives: Mesoporous silica materials, particularly KIT-6, offer promising features, such as large surface area, tunable pore structures, and biocompatibility, making them ideal candidates for advanced drug delivery systems. The aims of this study were to develop and evaluate an innovative modified-release platform for metformin hydrochloride (MTF), using KIT-6 mesoporous silica as a matrix, to enhance oral antidiabetic therapy. Methods: KIT-6 was synthesized using an ultrasound-assisted sol-gel method and subsequently loaded with MTF via adsorption from alkaline aqueous solutions at two concentrations (1 and 3 mg/mL). The structural and morphological characteristics of the matrices—before and after drug loading—were assessed using SEM-EDX, TEM, and nitrogen adsorption–desorption isotherms (the BET method). In vitro drug release profiles were recorded in simulated gastric and intestinal fluids over 12 h. Kinetic modeling was performed using seven classical models, and a multifractal theoretical framework was used to further interpret the complex release behavior. Results: The loading efficiency increased with increasing drug concentration but nonlinearly, reaching 56.43 mg/g for 1 mg/mL and 131.69 mg/g for 3 mg/mL. BET analysis confirmed significant reductions in the surface area and pore volume upon MTF incorporation. In vitro dissolution showed a biphasic release: a fast initial phase in an acidic medium followed by sustained release at a neutral pH. The Korsmeyer–Peppas and Weibull models best described the release profiles, indicating a predominantly diffusion-controlled mechanism. The multifractal model supported the experimental findings, capturing nonlinear dynamics, memory effects, and soliton-like transport behavior across resolution scales. Conclusions: The study confirms the potential of KIT-6 as a reliable and efficient carrier for the modified oral delivery of metformin. The combination of experimental and multifractal modeling provides a deeper understanding of drug release mechanisms in mesoporous systems and offers a predictive tool for future drug delivery design. This integrated approach can be extended to other active pharmaceutical ingredients with complex release requirements.


  • Open Access

    Formulation and In Vitro Evaluation of Matrix Tablets Containing Ketoprofen–Beta Cyclodextrin Complex for Enhanced Rheumatoid Arthritis Therapy: Experimental and Computational Insights

    by Monica Stamate Cretan, Lacramioara Ochiuz, Vlad Ghizdovat, Monica Molcalut, Maricel Agop, Carmen Anatolia Gafițanu, Alexandra Barsan (Bujor), Mousa Sha’at, Ciprian Stamate

    Background: Rheumatoid arthritis is a chronic autoimmune disease that leads to severe disability and requires improved therapeutic strategies to optimize anti-inflammatory treatment. This study aimed to address this challenge by developing and characterizing an extended-release polymer matrix tablet containing ketoprofen and a ketoprofen–β-cyclodextrin complex with enhanced therapeutic properties. The objective was to improve inflammation management and therapeutic outcomes using a novel delivery system based on the inclusion of the active substance in cyclodextrin complexes. Methods: Tablets were formulated using ketoprofen and ketoprofen–β-cyclodextrin complexes combined with hydrophilic polymers such as Carbopol® 971P NF, Kollidon® VA 64, and MethocelTM K4M. The complexes were obtained via the coprecipitation method to improve bioavailability. The kinetics of the release of ketoprofen, ketoprofen–β-cyclodextrin complex (2:1), and ketoprofen–β-cyclodextrin complex (1:1) from the tablets were investigated in vitro in artificial gastric and intestinal fluids, and drug release profiles were established. Advanced mathematical models were used to describe the nonlinear behavior of the drug–polymer systems. Results: The inclusion of ketoprofen in the β-cyclodextrin complexes was confirmed, revealing distinct release profiles. Tablets (K-3 F-3) containing the 1:1 complex showed rapid release (96.2% in 4–7 h), while tablets (K-1 F-4) containing free ketoprofen released 76% over 9–11 h. Higher polymer concentrations slowed the release due to gel barrier formation. Pharmacotechnical and stability tests supported their suitability as extended-release forms. A multifractal modeling approach described the release dynamics, treating the polymer–drug matrix as a complex system, with release curves characterized by variations in the fractal dimension and resolution. Conclusions: Specific hydrophilic polymer combinations effectively prolonged ketoprofen release. The developed matrix tablets, which were evaluated via in vitro studies and mathematical modeling, show promise for improving therapeutic outcomes and patient compliance during rheumatoid arthritis treatment.


  • Open Access

    Experimental and Theoretical Design on the Development of Matrix Tablets with Multiple Drug Loadings Aimed at Optimizing Antidiabetic Medication

    by Mousa Sha’at, Lacramioara Ochiuz, Cristina Marcela Rusu, Maricel Agop, Alexandra Barsan (Bujor), Monica Stamate Cretan, Mihaela Hartan, Adrian Florin Spac

    Background: Diabetes is a growing global health crisis that requires effective therapeutic strategies to optimize treatment outcomes. This study aims to address this challenge by developing and characterizing extended-release polymeric matrix tablets containing metformin hydrochloride (M-HCl), a first-line treatment for type 2 diabetes, and honokiol (HNK), a bioactive compound with potential therapeutic benefits. The objective is to enhance glycemic control and overall therapeutic outcomes through an innovative dual-drug delivery system. Methods: The tablets were formulated using hydrophilic polymers, such as Carbopol® 71G NF and Noveon® AA-1. The release kinetics of M-HCl and HNK were investigated through advanced mathematical models, including fractal and multifractal dynamics, to capture the non-linear and time-dependent release processes. Traditional kinetic models (zero-order, first-order, Higuchi equations) were also evaluated for comparison. In vitro dissolution studies were conducted to determine the release profiles of the active ingredients under varying polymer concentrations. Results: The study revealed distinct release profiles for the two active ingredients. M-HCl exhibited a rapid release phase, with 80% of the drug released within 4–7 h depending on polymer concentration. In contrast, HNK demonstrated a slower release profile, achieving 80% release after 9–10 h, indicating a greater sensitivity to polymer concentration. At shorter intervals, drug release followed classical kinetic models, while multifractal dynamics dominated at longer intervals. Higher polymer concentrations resulted in slower drug release rates due to the formation of a gel-like structure upon hydration, which hindered drug diffusion. The mechanical properties and stability of the matrix tablets confirmed their suitability for extended-release applications. Mathematical modeling validated the experimental findings and provided insights into the structural and time-dependent factors influencing drug release. Conclusions: This study successfully developed dual-drug extended-release matrix tablets containing metformin hydrochloride and honokiol, highlighting the potential of hydrophilic polymers to regulate drug release. The findings emphasize the utility of advanced mathematical models for predicting release kinetics and underscore the potential of these formulations to improve patient compliance and therapeutic outcomes in diabetes management.


  • Open Access

    Multifractal Analysis and Experimental Evaluation of MCM-48 Mesoporous Silica as a Drug Delivery System for Metformin Hydrochloride

    by Mousa Sha’at, Maria Ignat, Liviu Sacarescu, Adrian Florin Spac, Alexandra Barsan (Bujor), Vlad Ghizdovat, Emanuel Nazaretian, Catalin Dumitras, Maricel Agop, Cristina Marcela Rusu, et al.

    Background: This study explored the potential of MCM-48 mesoporous silica matrices as a drug delivery system for metformin hydrochloride, aimed at improving the therapeutic management of type 2 diabetes mellitus. The objectives included the synthesis and characterization of MCM-48, assessment of its drug loading capacity, analysis of drug release profiles under simulated physiological conditions, and the development of a multifractal dynamics-based theoretical framework to model and interpret the release kinetics. Methods: MCM-48 was synthesized using a sol–gel method and characterized by SEM-EDX, TEM, and nitrogen adsorption techniques. Drug loading was performed via adsorption at pH 12 using metformin hydrochloride solutions of 1 mg/mL (P-1) and 3 mg/mL (P-2). In vitro dissolution studies were conducted to evaluate the release profiles in simulated gastric and intestinal fluids. A multifractal dynamics model was developed to interpret the release kinetics. Results: SEM-EDX confirmed the uniform distribution of silicon and oxygen, while TEM images revealed a highly ordered cubic mesoporous structure. Nitrogen adsorption analyses showed a high specific surface area of 1325.96 m²/g for unloaded MCM-48, which decreased with drug loading, confirming efficient incorporation of metformin hydrochloride. The loading capacities were 59.788 mg/g (P-1) and 160.978 mg/g (P-2), with efficiencies of 99.65% and 89.43%, respectively. In vitro dissolution studies showed a biphasic release profile: an initial rapid release in gastric conditions followed by sustained release in intestinal fluids, achieving cumulative releases of 92.63% (P-1) and 82.64% (P-2) after 14 hours. The multifractal dynamics-based theoretical release curves closely matched the experimental data. Conclusions: MCM-48 mesoporous silica effectively enhanced metformin delivery, offering a controlled release profile well-suited for type 2 diabetes management. The multifractal theoretical framework provided valuable insights into drug release dynamics, contributing to the advancement of innovative drug delivery systems.


  • Open Access

    Development of an HPLC Method through the QbD Approach for the Quantification of Honokiol and Metformin Hydrochloride – Method Validation and Pharmaceutical Applications on Oral Dosage Forms

    by Mousa Sha’at, Adrian Florin Spac, Iulian Stoleriu, Alexandra Bujor, Monica Stamate Cretan, Mihaela Hartan, Lăcrămioara Ochiuz

    For quantitative determination of honokiol (HNK) and metformin hydrochloride (M-HCl) by HPLC from formulations and from dissolution studies, a QbD approach using three factors - three levels design was implemented to optimize the chromatographic conditions. To study the impact of each variable on the peak area of both compounds and retention time of last compound eluted, the 3D response surface plots were developed. HNK and M-HCl were separated on a Thermoscientific ODS Hypersyl TM (250 x 4.6 mm, 5 μm) column mantained at 30 C, using 0.02 M acetate buffer (pH = 3) / methanol (15 / 85, v / v) as mobile phase with a flow rate of 1 mL/min. The injected volume was 20 L, and the detection wavelengths were 256 nm for HNK and 236 nm for M-HCl. The validation of proposed method showed a linearity range of 4 – 1200 μg/mL for M-HCl (r2 = 0.9992) and 1 – 300 μg/mL for HNK (r2 = 0.9998), good precision (RSD < 2% for both HNK and M-HCl, in intra- and inter-day studies) and accuracy (mean recovery = 100.09% in the range 99.80 – 100.43% for M-HCl and mean recovery = 100.12% in the range 99.70 – 100.38% for HNK). The environmentally friendly nature of the method was confirmed by the evaluation of the method’s greenness. The proposed method was applied for the determination of HNK and M-HCl from oral dosage forms and in dissolution studies.

  • Mineral alchemy in dermatology: the use of zinc in cosmetics and in the treatment of dermatological diseases

    by Ilinca Onofrei, Lăcrămioara Ochiuz, Alexandra Bujor, Ionuţ-Iulian LUNGU, Alina Ştefanache

    The cosmetic industry is not a recent phenomenon, but a long-standing practice dating back hundreds of years. Both women and men used cosmetics not only to enhance physical appearance, but also to convey social and cultural meanings. Many of the products used were based on copper minerals, copper oxide, charcoal obtained by burning almonds, ash, powders and other chemical elements such as arsenic, characterized by a particular toxicity. Due to their antioxidant, anti-inflammatory, anti-pigmentation and antibacterial properties, minerals are frequently integrated into cosmetic product formulations. They play a crucial role in addressing and treating various dermatological conditions, providing therapeutic benefits and helping to improve the health of the skin and other aspects of the body. The daily intake of minerals is necessary for the harmonious and continuous basic functioning of the human body. These minerals are divided into two important categories: macroelements (calcium, magnesium, sodium, potassium etc) and trace elements (iron, copper, selenium, cobalt, zinc etc). In the following paper, I have highlighted the benefits brought by Zinc and its compounds to the Cosmetic Industry. The trace element is frequently used in the composition of cosmetics, as well as in the treatment of dermatological conditions.

  • Open Access

    Simultaneous Determination of Glibenclamide and Silymarin Released from Chitosan Microparticles by HPLC-ESI-MS Technique: Method Development and Validation

    by Mihaela-Iustina Condurache, Anca-Roxana Petrovici, Natalia Simionescu, Bianca-Stefania Profire, Luminita-Georgeta Confederat, Alexandra Bujor, Anca Miron, Lenuta Profire

    The study aim was to develop and validate a high-performance liquid chromatography–electrospray ionization mass spectrometry (HPLC-ESI-MS) method to simultaneously determine glibenclamide (Gli) and silymarin (Sil) released from chitosan (CS) microparticles in aqueous solutions. The CS microparticles were synthesized using an ionic gelation method, and their morphology, swelling degree, encapsulation efficiency and active substance release were investigated. Gli and Sil were loaded in different concentrations, and their identification and quantification were performed using the HPLC-ESI-MS method, which was further validated. The drugs’ characteristic m/z was found in the higher intensity of retention time (Rt) (Gli, 8.909 min; Sil A, 5.41 min; and Sil B, 5.66 min). The method selectivity and precision are very good, and the blank solution proved no interference. The linearity of the answer function is very good for Sil A (R2 = 1), Sil B (R2 = 0.9998) and Gli (R2 = 0.9991). For Gli, we obtained a limit of detection (LOD) = 0.038 mg/mL and limit of quantification (LOQ) = 1.275 mg/mL; for Sil A, a LOD = 0.285 mg/mL and LOQ = 0.95 mg/mL; and for Sil B, a LOD = 0.045 mg/mL and LOQ = 0.15 mg/mL. A high-resolution HPLC-ESI-MS method was developed and validated, which allowed the simultaneous determination of Gli and Sil loaded in CS microparticles, in a concentration range of 0.025–1 mg/mL.